Literature DB >> 27639522

10-Year Institutional Retrospective Case Series of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction (mMCAI).

Simon Lammy1, Basel Al-Romhain2, Laura Osborne3, Edward J St George2.   

Abstract

BACKGROUND: A 10-year (2005-2015) retrospective case series of patients undergoing decompressive craniectomy for malignant middle cerebral artery infarction (mMCAI) was undertaken.
METHODS: Patient demographics, comorbidities, pre- and postoperative neurologic state, operative timescales, craniectomy dimensions, and Glasgow Outcome Scale scores were analyzed.
RESULTS: Overall 40 patients underwent a decompressive craniectomy for mMCAI with a 30-day mortality of 17.5% (n = 7). Seventeen patients (42.5%) were male, with a mean age of 43 years (range: 16-64 years). Patients who survived had a lower mean age of 41 years (range: 16-59 years) than those who did not of 50 years (range: 42-63 years). The modal ictal and preoperative Glasgow Coma Scale scores were 14 (range: 5-15) and 7 (range: 3-12), which corresponded to motor scores of 6 and 5, respectively. The mean time from ictus to admission to the Institute of Neurological Sciences (INS) was 23.5 hours (range: 0.5-66 hours) and from INS admission to decompression 7.5 hours (range: 0.5-46 hours). Approximately 60% of patients had an "early" craniectomy (under 48 hours from ictus) and 60% of patients had a craniectomy performed less than 24 hours from INS admission. The mean maximum anteroposterior craniectomy diameter measured 13 cm (range: 10.93-15.12 cm) and the mean surface area was 92.68 cm2 (range: 76.14-124.42 cm2). Overall 80% of patients had a modal Glasgow Outcome Scale score of 3 (range: 2-5) at discharge, 3 months, 6 months, 9 months, and 12 months. The median length of stay was 3 days (range: 6 hours to 11 days) for nonsurvivors and 13 days (range: 1-365 days) for survivors.
CONCLUSION: Decompressive craniectomy for mMCAI is suitable in selected patients, and the local practice is consistent with current evidence. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Craniectomy; Decompressive; Glasgow Outcome Scale Score; Malignant; Mortality

Mesh:

Year:  2016        PMID: 27639522     DOI: 10.1016/j.wneu.2016.09.004

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Factors Associated with the Outcome of Very Elderly Patients with Large Hemispheric Infarction Treated with Medical Management Only.

Authors:  Sudhir Datar; Christopher McLouth; Patrick Reynolds
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

2.  The Wessex modified Richmond Sedation Scale as a novel tool for monitoring patients at risk of malignant MCA syndrome.

Authors:  Tayyib T A Hayat; Matthew A Myers; John Hell; Matthew Cordingly; Diederik O Bulters; Nicolas Weir; George Pengas
Journal:  Acta Neurochir (Wien)       Date:  2018-04-11       Impact factor: 2.216

3.  Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial.

Authors:  Leila Dehghani; Arash Khojasteh; Masoud Soleimani; Saeed Oraee-Yazdani; Saeed Heidari Keshel; Mohammad Saadatnia; Masih Saboori; Alireza Zali; Seyed Mahmoud Hashemi; Reyhane Soleimani
Journal:  Int J Prev Med       Date:  2022-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.